Inventor
STAEHLE WOLFGANG
DE35 patents
⚠️ This page may combine multiple inventors who share the name “STAEHLE WOLFGANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK PATENT GMBH
18 patentsUS7470702B2Dec 30, 2008
Benzimidazoles
MERCK PATENT GMBH14 citations84
US7138417B2Nov 21, 2006
Inhibitors of integrin αvβ6
MERCK PATENT GMBH17 citations84
US9809552B2Nov 7, 2017
Piperazine derivatives as FASN inhibitors
MERCK PATENT GMBH8 citations82
US7547695B2Jun 16, 2009
Pyridopyrimidinones
MERCK PATENT GMBH11 citations80
US9452997B2Sep 27, 2016
Piperidine and piperazine derivatives as autotaxin inhibitors
MERCK PATENT GMBH4 citations73
US9670142B2Jun 6, 2017
1,3-diaminocyclopentane carboxamide derivatives
MERCK PATENT GMBH4 citations72
US6576637B1Jun 10, 2003
β-alanine derivatives
MERCK PATENT GMBH10 citations70
US6521646B1Feb 18, 2003
Dibenzoazulene derivatives for treating thrombosis, osteoporosis, arteriosclerosis
MERCK PATENT GMBH4 citations62
US10118919B2Nov 6, 2018
3-substituted cyclopentylamine derivatives
MERCK PATENT GMBH0 citations52
US9790216B2Oct 17, 2017
3-substituted cyclopentylamine derivatives
MERCK PATENT GMBH0 citations52
US7632951B2Dec 15, 2009
Inhibitors of integrin ανβ6
MERCK PATENT GMBH1 citations52
US7915416B2Mar 29, 2011
Tetrahydroquinolines
MERCK PATENT GMBH1 citations51
US9416133B2Aug 16, 2016
Hydropyrrolopyrrole derivatives for use as fatty acid synthase inhibitors
MERCK PATENT GMBH1 citations48
US7135587B2Nov 14, 2006
Urea and urethane derivatives as integrin inhibitors
MERCK PATENT GMBH0 citations42
US9718785B2Aug 1, 2017
1,3-Disubstituted cyclopentane derivatives
MERCK PATENT GMBH0 citations41
US7696224B2Apr 13, 2010
Phenylurea derivatives as inhibitors of tyrosine kinases for the treatment of tumour diseases
MERCK PATENT GMBH0 citations41
US7528139B2May 5, 2009
Sulfonamides
MERCK PATENT GMBH0 citations41
US9732032B2Aug 15, 2017
3-aminocyclopentane carboxamide derivatives
MERCK PATENT GMBH0 citations36
STAEHLE WOLFGANG
7 patentsUS9029387B2May 12, 2015
Benzonaphthyridinamines as autotaxin inhibitors
STAEHLE WOLFGANG24 citations92
US8841324B2Sep 23, 2014
Heterocyclic compounds as autotaxin inhibitors
STAEHLE WOLFGANG28 citations92
US8912202B2Dec 16, 2014
N-(benzimimdazol-2-yl)-cyclopropane carboxamides as lysophosphatidic acid antagonists
STAEHLE WOLFGANG11 citations83
US8110583B2Feb 7, 2012
Tetrahydroquinoline derivatives
STAEHLE WOLFGANG4 citations61
US8242128B2Aug 14, 2012
1,3-benzoxazolyl derivatives as kinase inhibitors
STAEHLE WOLFGANG1 citations51
US8097727B2Jan 17, 2012
N,N′-diphenylurea derivatives which are suitable as kinase inhibitors
STAEHLE WOLFGANG0 citations51
US9283225B2Mar 15, 2016
Pyrido-pyrimidine derivatives
STAEHLE WOLFGANG0 citations40
SCHIEMANN KAI
6 patentsUS8557824B2Oct 15, 2013
Thiazole derivatives
SCHIEMANN KAI14 citations83
US8552001B2Oct 8, 2013
Sulfoxide derivatives for the treatment of tumors
SCHIEMANN KAI14 citations83
US8530650B2Sep 10, 2013
2, 5-diamino-substituted pyrido [4, 3-D] pyrimidines as autotaxin inhibitors against cancer
SCHIEMANN KAI17 citations82
US8822476B2Sep 2, 2014
Piperidine and piperazine derivatives as autotaxin inhibitors
SCHIEMANN KAI2 citations62
US9527850B2Dec 27, 2016
Benzyl piperidine compounds as lysophosphatidic acid (LPA) receptor antagonist
SCHIEMANN KAI2 citations61
US8859775B2Oct 14, 2014
Pyrazolopyridinone derivatives as LPA receptor antagonists
SCHIEMANN KAI0 citations51